These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 28652386
1. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening. Kjærgaard KA, Christiansen MK, Schmidt M, Olsen MS, Jensen HK. J Am Heart Assoc; 2017 Jun 26; 6(6):. PubMed ID: 28652386 [Abstract] [Full Text] [Related]
2. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Besseling J, Huijgen R, Martin SS, Hutten BA, Kastelein JJ, Hovingh GK. Atherosclerosis; 2016 Mar 26; 246():1-6. PubMed ID: 26745182 [Abstract] [Full Text] [Related]
3. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry. Béliard S, Boccara F, Cariou B, Carrié A, Collet X, Farnier M, Ferrières J, Krempf M, Peretti N, Rabès JP, Varret M, Vimont A, Charrière S, Bruckert E, French FH Registry group. Atherosclerosis; 2018 Oct 26; 277():334-340. PubMed ID: 30270068 [Abstract] [Full Text] [Related]
4. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. Circ Cardiovasc Genet; 2016 Jun 26; 9(3):240-9. PubMed ID: 27013694 [Abstract] [Full Text] [Related]
5. Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010. Mundal L, Sarancic M, Ose L, Iversen PO, Borgan JK, Veierød MB, Leren TP, Retterstøl K. J Am Heart Assoc; 2014 Dec 02; 3(6):e001236. PubMed ID: 25468658 [Abstract] [Full Text] [Related]
10. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle. Shek A, Alieva R, Kurbanov R, Hoshimov S, Nizamov U, Abdullaeva G, Nagay A. Atherosclerosis; 2018 Oct 02; 277():524-529. PubMed ID: 30270094 [Abstract] [Full Text] [Related]
11. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study). Pérez de Isla L, Alonso R, Mata N, Saltijeral A, Muñiz O, Rubio-Marin P, Diaz-Diaz JL, Fuentes F, de Andrés R, Zambón D, Galiana J, Piedecausa M, Aguado R, Mosquera D, Vidal JI, Ruiz E, Manjón L, Mauri M, Padró T, Miramontes JP, Mata P, SAFEHEART Investigators. Arterioscler Thromb Vasc Biol; 2016 Sep 02; 36(9):2004-10. PubMed ID: 27444203 [Abstract] [Full Text] [Related]
12. Statins for children with familial hypercholesterolemia. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Cochrane Database Syst Rev; 2017 Jul 07; 7(7):CD006401. PubMed ID: 28685504 [Abstract] [Full Text] [Related]
13. Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study. Kjærgaard KA, Harborg S, Jensen HK, Borgquist S. Lipids Health Dis; 2022 Jul 02; 21(1):56. PubMed ID: 35780163 [Abstract] [Full Text] [Related]
14. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE. Heart; 2011 Jul 02; 97(14):1175-81. PubMed ID: 21685482 [Abstract] [Full Text] [Related]
15. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan. Hsiung YC, Lin PC, Chen CS, Tung YC, Yang WS, Chen PL, Su TC. Atherosclerosis; 2018 Oct 02; 277():440-447. PubMed ID: 30270083 [Abstract] [Full Text] [Related]
16. Mutational analysis of the LDLR gene in a cohort of Colombian families with familial hypercholesterolemia. López G, Bernal LM, Gelvez N, Gómez LF, Nova A, Sánchez AI, Tamayo ML. Atherosclerosis; 2018 Oct 02; 277():434-439. PubMed ID: 30270082 [Abstract] [Full Text] [Related]
17. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P, Gentile M, Marotta G, Iannuzzi A, Sodano M, De Simone B, Jossa F, Iannuzzo G, Giacobbe C, Di Taranto MD, Fortunato G. Eur J Prev Cardiol; 2017 Jul 02; 24(10):1051-1059. PubMed ID: 28353356 [Abstract] [Full Text] [Related]
18. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. van Delden XM, Huijgen R, Wolmarans KH, Brice BC, Barron JK, Blom DJ, Marais AD. Atherosclerosis; 2018 Oct 02; 277():327-333. PubMed ID: 30270067 [Abstract] [Full Text] [Related]
19. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families. Wu X, Pang J, Wang X, Peng J, Chen Y, Wang S, Watts GF, Lin J. Clin Cardiol; 2017 Nov 02; 40(11):1169-1173. PubMed ID: 29168983 [Abstract] [Full Text] [Related]
20. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population. Séguro F, Bongard V, Bérard E, Taraszkiewicz D, Ruidavets JB, Ferrières J. Arch Cardiovasc Dis; 2015 Oct 02; 108(10):511-8. PubMed ID: 26073227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]